Major Sponsors
Janssen-Cilag Australia
"Caring for the world one person at a time"
Driven by our Statement of Caring, Janssen-Cilag Australia embraces research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Janssen-Cilag Australia is a leading research-based pharmaceutical company, employing more than 320 staff in Australia.
Janssen-Cilag provides prescription medicines for a range of conditions in the areas of mental health, neurology, women's health, haematology, gastroenterology, and pain management. The research conducted by Janssen-Cilag Australia has resulted in a number of critical medicines being developed and made available to the Australian public.
Eli Lilly Australia
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives.
As a leading healthcare corporation, Eli Lilly Australia is continually delivering medical solutions that enable people to live longer and healthier lives. For almost 50 years Lilly has provided Australians with innovative medicines to treat a number of serious health conditions including depression, schizophrenia, bipolar disorder, diabetes, osteoporosis, erectile dysfunction and cancer. With roughly $40 million spent every year on research and development in Australia, Lilly is committed to continually finding solutions for unmet medical need to help provide answers that matter for Australian patients.
AstraZeneca
As one of the world's leading pharmaceutical companies, AstraZeneca is engaged in the research, development, manufacture, and supply of medicines that make a difference for patients in important areas of healthcare.
AstraZeneca provides healthcare solutions designed to fight diseases in seven major therapeutic areas including cardiovascular, neuroscience, gastrointestinal, infection, oncology, anaesthesia (including pain management) and respiratory products.
Globally, the Company spends more than $16 million every working day on R&D, with more than 13,000 researchers dedicated to the discovery and development of innovative new medicines that meet the needs of patients worldwide.
Locally, AstraZeneca has spent over $250 million over the last decade on R&D, and is currently involved in over 50 clinical trials at over 200 sites across Australia.
AstraZeneca’s Sydney manufacturing facility is a key part of the global manufacturing network, employing more than 500 people and providing niche products to 37 international markets.
Sponsor
Industry & Investment NSW
Industry & Investment NSW has been established to assist in building a diversified state economy that creates jobs. We aim to attract investment to NSW and support innovative, sustainable and globally competitive industries through our strong technical knowledge and scientific capabilities. We do this through effective partnerships with our industry sectors and by linking them to our state's knowledge and skills capacity. Part of Industry & Investment NSW, the NSW Office for Science and Medical Research plays a crucial role in bringing together the diverse strands of scientific and medical research endeavour in NSW and providing support and an increased public profile for the sector.
Etihad Airways
As the National Airline of the United Arab Emirates, Etihad Airways seeks to reflect the best of Arabian hospitality - cultured, considerate, warm and generous - as well as enhance the prestige of Abu Dhabi as a centre of hospitality between East and West. Our goal is to be a truly 21st century, global airline, challenging and changing the established conventions of airline hospitality.
As a global, innovative and young airline with a fresh approach to everything we do, we associate ourselves with a large number of events and causes that reflect our own position as a catalyst for change. We support the promotion of local culture in the UAE and worldwide, and sponsor cultural and sporting events that are consistent with our values of hospitality, team spirit and helping to bring the world together.
Lundbeck Australia
Lundbeck Australia employs approximately 55 people locally and markets Lexapro (escitalopram) an SSRI for depression and anxiety disorders, Ebixa (memantine) a treatment for Alzheimer's Disease as well as Clopixol (Zuclopenthixol) and Fluanxol (Flupenthixol). Lundbeck Australia strengthens the company's position as Specialist in Central Nervous System disorders.
It is part of the Lundbeck Australia philosophy that our role with the medical profession is one of education and support. For this reason from our establishment in 1997 we have ensured that our activities and resources are focused on providing information, educational books and meetings.
By providing educational and supportive platforms for both learning and teaching we aim to develop an understanding with treating physicians and care providers which helps us identify areas that require more focus, or future research.
Mental Health Council of Australia
The Mental Health Council of Australia (MHCA) is the peak, national non-government organisation representing and promoting the interests of the Australian mental health sector, committed to achieving better mental health for all Australians.
MHCA Members include national organisations representing consumers, carers, special needs groups, clinical service providers, public and private mental health service providers, researchers and state/territory community mental health peak bodies.
The MHCA aims to:
- Promote mentally healthy communities
- Educate Australians on mental health issues
- Conduct research into mental health issues
- Reform Australia's mental health system
For further information about the MHCA and their work you can go to their website www.mhca.org.au
The Ian Potter Foundation
Sir Ian Potter established The Ian Potter Foundation in 1964. Now one of Australia’s leading philanthropic foundations, the Governors and staff of the Foundation endeavour to uphold Sir Ian’s legacy by supporting Australia’s community leaders and innovators to bring positive change to our society. The Ian Potter Foundation donates nationally, supporting a wide range of projects across many sectors of the community.
The Ian Potter Foundation’s conference grants program is an important aspect of its commitment to excellence, particularly as it relates to exchanging and sharing knowledge.
Sponsorship and Exhibition Opportunities
ASC 2010 will provide a unique educational environment dedicated to the exchange of leading edge scientific research, training and commercial intelligence.
If practising psychiatrists, other medical practitioners, psychologists, research scientists, clinical educators, nurses and other mental health workers are part of your target market there is no better way to reach them all in one Conference.
Early confirmation of your sponsorship of the Conference will ensure an even higher level of exposure. An extensive promotional campaign including advertisements, direct mail campaigns, email broadcasts and web exposure will be implemented in the lead up to the Conference and the opportunity exists for your company to be represented as a key supporter of the Conference well in advance of the 22nd September 2010.
To view the Sponsorship and Exhibition opportunities please click here.
For any sponsorship and exhibition enquiries, please contact:
Fallon Smith
Sponsorship and Exhibition Manager
T: (+61 2) 9254 5000
F: (+61 2) 9251 3552
Email: sponsorship@asc2010.com
|
